{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oxygen+21+%25&page=4", "query": { "intervention": "Oxygen 21 %", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 99, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oxygen+21+%25&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Oxygen+21+%25&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T20:03:53.253Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03833674", "title": "FLO2 for Recovery After SCI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injury (SCI)" ], "interventions": [ { "name": "Daily AIH Block", "type": "OTHER" }, { "name": "Sham dAIH Block", "type": "OTHER" }, { "name": "Respiratory Strength Training Block", "type": "OTHER" }, { "name": "AIH + Strength Training Block", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 43, "start_date": "2020-08-15", "completion_date": "2024-02-20", "has_results": false, "last_update_posted_date": "2024-05-29", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03833674" }, { "nct_id": "NCT05289310", "title": "Low Oxygen Exposure and Weight Status", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Normobaric hypoxia (NH)", "type": "OTHER" }, { "name": "Normobaric normoxia (NN)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Pennington Biomedical Research Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "22 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2023-05-16", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05289310" }, { "nct_id": "NCT06622005", "title": "SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Multiple Myeloma", "Refractory Multiple Myeloma" ], "interventions": [ { "name": "Cxcr1/2 Inhibitor SX-682", "type": "DRUG" }, { "name": "Daratumumab and Recombinant Human Hyaluronidase", "type": "DRUG" }, { "name": "Carfilzomib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2025-04-10", "completion_date": "2030-04-10", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06622005" }, { "nct_id": "NCT01773746", "title": "Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Extreme Prematurity - Less Than 28 Weeks" ], "interventions": [ { "name": "Neonatal Resuscitation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Sharp HealthCare", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 80, "start_date": "2013-08", "completion_date": "2017-03-01", "has_results": false, "last_update_posted_date": "2018-09-12", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 6, "location_summary": "San Diego, California • Farmington, Connecticut • Miami, Florida + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01773746" }, { "nct_id": "NCT05924022", "title": "Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "Hyperbaric Oxygen Treatment Full", "type": "COMBINATION_PRODUCT" }, { "name": "Hyperbaric Oxygen Treatment Sham", "type": "COMBINATION_PRODUCT" }, { "name": "Hyperbaric Oxygen Treatment Partial Pressure", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Washington State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2023-12-04", "completion_date": "2025-08-15", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Spokane, Washington", "locations": [ { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05924022" }, { "nct_id": "NCT03262766", "title": "Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries" ], "interventions": [ { "name": "Acute Intermittent Hypoxia (AIH)", "type": "OTHER" }, { "name": "Upper extremity training", "type": "BEHAVIORAL" }, { "name": "Sham Acute intermittent hypoxia", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 80, "start_date": "2017-06-24", "completion_date": "2020-10-30", "has_results": false, "last_update_posted_date": "2020-02-19", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03262766" }, { "nct_id": "NCT04626791", "title": "Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mantle Cell Lymphoma" ], "interventions": [ { "name": "Acalabrutinib", "type": "DRUG" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Rituximab and Hyaluronidase Human", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 41, "start_date": "2021-08-03", "completion_date": "2028-08-03", "has_results": true, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 3, "location_summary": "New York, New York • Charlotte, North Carolina • Seattle, Washington", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04626791" }, { "nct_id": "NCT01954901", "title": "Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wagner Grade 2 Lower Extremity Ulcers" ], "interventions": [ { "name": "Hyperbaric oxygen therapy", "type": "DEVICE" }, { "name": "Hyperbaric room air", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "David Grant U.S. Air Force Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2013-10", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2020-04-17", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Travis Air Force Base, California", "locations": [ { "city": "Travis Air Force Base", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01954901" }, { "nct_id": "NCT04447716", "title": "An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent B-Cell Non-Hodgkin Lymphoma", "Recurrent Follicular Lymphoma", "Recurrent Indolent Adult Non-Hodgkin Lymphoma", "Recurrent Marginal Zone Lymphoma", "Refractory B-Cell Non-Hodgkin Lymphoma", "Refractory Follicular Lymphoma", "Refractory Indolent Adult Non-Hodgkin Lymphoma", "Refractory Marginal Zone Lymphoma" ], "interventions": [ { "name": "Venetoclax", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Rituximab and Hyaluronidase Human", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2020-10-16", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04447716" }, { "nct_id": "NCT06276634", "title": "Intermittent Hypoxia in Persons With Multiple Sclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis", "Multiple Sclerosis-Relapsing-Remitting", "Multiple Sclerosis, Secondary Progressive" ], "interventions": [ { "name": "Acute Intermittent Hypoxia", "type": "OTHER" }, { "name": "Sham-Acute Intermittent Hypoxia", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 21, "start_date": "2024-04-30", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-03-20", "last_synced_at": "2026-10-05T20:03:53.253Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06276634" } ] }